Sort
261,768 grants matching “gene therapy”
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,368,990Joel Moss · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Molecular and Genetic Characterization of Human Gliomas to Identify New Targets
$2,368,649Howard A Fine · Clinical Sciences · Z01 · FY2007 · CA
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,368,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2021 · HL
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,368,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2019 · HL
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,368,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2020 · HL
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,368,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2022 · HL
Characterizing the gut microbial ecosystem for diagnosis and therapy in IBD
$2,368,101Ramnik J Xavier · Broad Institute, Inc. · U54 · FY2015 · DK
Genes and signals controlling mammalian hematopoiesis.
$2,368,007Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Individualizing Therapy for Kidney and Heart Transplant Recipients
$2,367,532Peter Scott Heeger · Icahn School Of Medicine At Mount Sinai · U01 · FY2011 · AI
Development of Novel Therapeutic Strategies in Human Leukemias
$2,367,210James D Griffin · Dana-Farber Cancer Inst · P01 · FY2009 · CA
ECOG Statistical Office
$2,367,125Robert J Gray · Dana-Farber Cancer Inst · U10 · FY2008 · CA
ECOG Statistical Office
$2,367,125Robert J Gray · Dana-Farber Cancer Inst · U10 · FY2007 · CA
Noninvasive and predictive biomarkers of organ transplant rejection
$2,367,000Gabriel A Kwong · Georgia Institute Of Technology · DP2 · FY2016 · HD
Harnessing the power of experimental genetic crosses and systems genetics to probe drug resistance in malaria
$2,366,515Michael T Ferdig · University Of Notre Dame · P01 · FY2020 · AI
Harnessing the power of experimental genetic crosses and systems genetics to probe drug resistance in malaria
$2,366,515Michael T Ferdig · University Of Notre Dame · P01 · FY2019 · AI
Silvio O. Conte Center for Oxytocin and Social Cognition
$2,366,480Larry J Young · Emory University · P50 · FY2021 · MH
Reactive oxygen species and anti-oxidants in ALI
$2,366,381Aron B. Fisher · University Of Pennsylvania · P01 · FY2006 · HL
Role of Sphingolipids in the Pathobiology of Lung Injury
$2,366,349Viswanathan Natarajan · University Of Illinois At Chicago · P01 · FY2011 · HL
Mechanisms of Circadian and Synaptic Dysfunction After Repetitive Mild TBI
$2,366,184Michael J Whalen · Massachusetts General Hospital · RF1 · FY2022 · NS
Dissecting the neurobiological basis of social control over alcohol self-administration
$2,365,880Brendan Tunstall · University Of Tennessee Health Sci Ctr · R01 · FY2025 · AA
Mechanisms regulating neuronal degeneration and repair
$2,365,793Claire Le Pichon · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial
$2,365,589Parambir Singh Dulai · Northwestern University At Chicago · U01 · FY2024 · DK
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,365,134Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Endothelial Dysfunction and Restoration in Trauma Induced Coagulopathy
$2,365,012Matthew D Neal · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
SPORE in Prostate Cancer
$2,364,931Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA